Research presented at CHEST 2021 examined how expanded USPSTF lung cancer screening criteria would affect minorities and women.
Sleep apnea research presented at CHEST 2021 examined links between PAP therapy adherence and the prevalence and severity of excessive daytime sleepiness.
Is long-term oxygen therapy needed by most patients after hospitalization for COVID-19?
Pooled data from the LEAP 1 and 2 trials were used to study the efficacy and safety of lefamulin in patients with CABP at risk for severe pneumonia.
An analysis of the CHRONICLE study of severe, uncontrolled asthma showed biologics decreased exacerbations in patient subgroups not previously included in RCTs.
Is there a clinical correlation between patient outcomes for COVID-19 and the use and dosage of acetaminophen?
Is asthma triple therapy with umeclidinium plus fluticasone furoate/vilanterol effective for patients with uncontrolled asthma who overuse SABA as rescue therapy?
Which therapy more effectively reduces severe COPD exacerbations: once-daily FF/UMEC/VI or twice-daily ICS/LABA?
With cannabis use on the rise, what do we know about patients with asthma who use cannabis?
Research presented at CHEST 2021 assessed an alternative approach to predicting COPD exacerbations during the COVID-19 pandemic.